Pages that link to "Q41189090"
Jump to navigation
Jump to search
The following pages link to Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal (Q41189090):
Displaying 50 items.
- Estrogens, inflammation and cognition (Q26771644) (← links)
- Acetylsalicylic acid as an adjuvant therapy for schizophrenia (Q28200931) (← links)
- In vivo indomethacin treatment causes microglial activation in adult mice (Q28376563) (← links)
- Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology (Q30658083) (← links)
- Post-dexamethasone cortisol level and memory performance in elderly depressed patients (Q31859338) (← links)
- Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection (Q33204250) (← links)
- CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation (Q33334431) (← links)
- The evolution of aging-related brain change (Q33799169) (← links)
- Dietary modulation of prostanoid synthesis in the aging process: role of cyclooxygenase-2. (Q33828732) (← links)
- Over-the-counter analgesics and antipyretics: a critical assessment (Q33906949) (← links)
- Strategies to delay the onset of Alzheimer's disease. (Q34039304) (← links)
- Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s (Q34066971) (← links)
- Anti-inflammatory drugs: a hope for Alzheimer's disease? (Q34074779) (← links)
- COX-2 and Alzheimer's disease: potential roles in inflammation and neurodegeneration. (Q34119479) (← links)
- Preventing dementia (Q34174220) (← links)
- Alzheimer's disease: its diagnosis and pathogenesis. (Q34349174) (← links)
- Prevalence of the major mental disorders among the Korean elderly (Q34451813) (← links)
- Dementia epidemiology (Q34777681) (← links)
- Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease (Q35009772) (← links)
- Mild cognitive impairment clinical trials (Q35194758) (← links)
- Kaempferol acts through mitogen-activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells (Q35376097) (← links)
- Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications (Q35482194) (← links)
- Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development (Q36318080) (← links)
- The triggering receptor expressed on myeloid cells 2: "TREM-ming" the inflammatory component associated with Alzheimer's disease (Q36711780) (← links)
- Neuroinflammatory processes in Alzheimer's disease (Q37772809) (← links)
- Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease (Q38108433) (← links)
- Regulation of IL-1β-induced cyclooxygenase-2 expression by interactions of Aβ peptide, apolipoprotein E and nitric oxide in human neuroglioma (Q39439875) (← links)
- The end of Alzheimer's disease? (Q40802219) (← links)
- Anti-inflammatory substances - a new therapeutic option in Alzheimer's disease (Q40810900) (← links)
- Advances and challenges in the prevention and treatment of Alzheimer's disease (Q41751974) (← links)
- Differential effects of estrogen in the injured forebrain of young adult and reproductive senescent animals. (Q42445263) (← links)
- Pathophysiological aspects of frontotemporal dementia--emphasis on cytoskeleton proteins and autoimmunity. (Q43758855) (← links)
- In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease (Q43791428) (← links)
- Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. (Q43892559) (← links)
- The effect of IL4 +33C/T polymorphism on risk of Japanese sporadic Alzheimer's disease (Q43957525) (← links)
- Metabolic profile of NO-flurbiprofen (HCT1026) in rat brain and plasma: a LC-MS study. (Q44071542) (← links)
- Dietary conjugated linoleic acid reduces cerebral prostaglandin E(2) in mice (Q44397675) (← links)
- Induction of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma during nitric oxide-induced apoptotic PC12 cell death (Q44807284) (← links)
- 15-Deoxy-Delta12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis (Q45023576) (← links)
- Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease (Q47678073) (← links)
- Glucocorticoids stimulate inflammatory 5-lipoxygenase gene expression and protein translocation in the brain (Q48148993) (← links)
- Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS. (Q48285765) (← links)
- Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease (Q48373983) (← links)
- Intracerebral inflammation after human brain contusion (Q48524421) (← links)
- Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex (Q48549483) (← links)
- Mouse cerebral prostaglandins, but not oxidative damage, change with age and are responsive to indomethacin treatment (Q48669202) (← links)
- Activation of complement and contact system in Alzheimer's disease. (Q48762237) (← links)
- Astrocytes contribute to neuronal impairment in beta A toxicity increasing apoptosis in rat hippocampal neurons. (Q48930118) (← links)
- Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type. (Q52033145) (← links)
- Treatment of Alzheimer's disease: current approaches and promising developments. (Q52039152) (← links)